Your session is about to expire
← Back to Search
HHD Measurement for Muscle Strength in Stroke Patients
N/A
Recruiting
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ability to follow two-step commands
Age 18 years or older
Must not have
Active infection and/or injury at location of testing site
Lower extremity contractures preventing full passive range of motion (ROM)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if HHD can more accurately measure leg muscle strength in stroke patients to better inform therapy.
Who is the study for?
This trial is for adults over 18 who've had a stroke at least 3 months ago and can follow simple commands. They must be able to hold certain positions like sitting or lying down during tests. People with severe limb stiffness, unstable vital signs, symptoms like shortness of breath or dizziness, active infections at the test site, or other serious health issues affecting physical activity cannot join.
What is being tested?
The study is testing if hand-held dynamometry (HHD), a tool for measuring muscle strength in the legs, can provide accurate data for therapists treating patients with chronic stroke. It will measure normal values of leg muscle force in different ways to see how well it works.
What are the potential side effects?
There are no direct side effects mentioned from using HHD as it's a non-invasive measurement tool. However, participants may experience general fatigue or discomfort from maintaining test positions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can understand and follow two-step instructions.
Select...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have an infection or injury where the test will be done.
Select...
I cannot fully move my legs due to stiffness.
Select...
I do not have symptoms like severe shortness of breath, chest pain, dizziness, severe headaches, sudden weakness or numbness, or leg pain suggesting a deep vein clot.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Hand-held Dynamometry Measurement of Average Force Production
Secondary study objectives
Hand-held Dynamometry Measurement of Peak Force Production
Other study objectives
Hand-held Dynamometry Measurement of Time to Peak Force
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Average Force ProductionExperimental Treatment1 Intervention
Average force production of bilateral lower extremities will be collected using the handheld dynamometer, Activbody Activ5.
Find a Location
Who is running the clinical trial?
Vanderbilt University Medical CenterLead Sponsor
908 Previous Clinical Trials
934,820 Total Patients Enrolled
12 Trials studying Stroke
5,996 Patients Enrolled for Stroke
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your resting heart rate, blood pressure, or oxygen level is not suitable for exercise.You have other health conditions that would make it difficult for you to take part in physical activities.I have an infection or injury where the test will be done.I can understand and follow two-step instructions.I am 18 years old or older.I cannot fully move my legs due to stiffness.I had a stroke more than 3 months ago.I do not have symptoms like severe shortness of breath, chest pain, dizziness, severe headaches, sudden weakness or numbness, or leg pain suggesting a deep vein clot.I can sit and lie in all positions needed for tests.
Research Study Groups:
This trial has the following groups:- Group 1: Average Force Production
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.